In this episode of Out of Network, Dr. Ryon Parker and Dr. Rishi Seth dive deep into the explosive world of GLP-1 medications—exploring the realities of semaglutide, tirzepatide, Ozempic, Wegovy, and Zepbound. With a projected $200 billion market by 2029, these drugs have transformed weight management, but they've also created chaos in the healthcare landscape. From med spa injections to proper medical supervision, this conversation sheds light on what safe GLP-1 treatment should actually look like.
What You'll Learn
Timestamps
Connect with Out of Network:
🌐 Website: https://www.outofnetworkpod.com/
📱 Instagram: https://www.instagram.com/outofnetworkpodcast/
▶️ YouTube: https://www.youtube.com/@OutofNetworkPodcast
🎵 TikTok: https://www.tiktok.com/@outofnetworkpodcast
Connect with the Hosts:
Dr. Ryon Parker → https://www.instagram.com/dr.ryonparker/
Parker Medical: https://parkermedical.org/
Dr. Rishi Seth → https://www.instagram.com/drrishiseth/
Seth Premiere Medical: https://sethmedical.com/
Enjoyed the Episode?
If this conversation resonated with you, please like, comment, and subscribe. Share it with someone who cares about the future of healthcare.
🎙 About Out of Network
Out of Network is a bold, physician-led podcast hosted by Dr. Ryon Parker and Dr. Rishi Seth. Each week, they challenge the broken healthcare system and explore how medicine can be reimagined—through patient-first care, prevention, and real human stories.
Enjoyed the Episode?
If you liked this conversation, please subscribe, leave us a review, and share this podcast with a friend—it helps more people discover a new vision for healthcare.